PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
215.00 - 235.00
210.00 - 590.00
2.95M / 482.4K (Avg.)
11.40 | 0.20
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
801.86%
10Y revenue/share CAGR above 1.5x MCB.L's 32.32%. David Dodd would confirm if management’s strategic vision consistently outperforms the competitor.
140.21%
5Y revenue/share CAGR above 1.5x MCB.L's 38.17%. David Dodd would look for consistent product or market expansions fueling outperformance.
147.07%
3Y revenue/share CAGR above 1.5x MCB.L's 42.09%. David Dodd would confirm if there's an emerging competitive moat driving recent gains.
-252.00%
Negative 10Y OCF/share CAGR while MCB.L stands at 49.53%. Joel Greenblatt would scrutinize managerial effectiveness and product competitiveness.
-265.73%
Negative 5Y OCF/share CAGR while MCB.L is at 124.40%. Joel Greenblatt would question the firm’s operational model or cost structure.
-180.33%
Negative 3Y OCF/share CAGR while MCB.L stands at 1106.92%. Joel Greenblatt would demand an urgent turnaround in the firm’s cost or revenue drivers.
611.51%
Net income/share CAGR above 1.5x MCB.L's 289.41% over 10 years. David Dodd would confirm if brand, IP, or scale secure this persistent advantage.
4892.57%
5Y net income/share CAGR above 1.5x MCB.L's 438.52%. David Dodd would confirm if the firm’s strategy is more effective in generating mid-term profits.
5793.15%
3Y net income/share CAGR above 1.5x MCB.L's 237.04%. David Dodd would confirm the company’s short-term strategies outmatch the competitor significantly.
No Data
No Data available this quarter, please select a different quarter.
30.69%
5Y equity/share CAGR at 75-90% of MCB.L's 36.61%. Bill Ackman might push for an improved ROE or share repurchase strategy to keep up.
43.45%
3Y equity/share CAGR above 1.5x MCB.L's 28.39%. David Dodd verifies the company’s short-term capital management far exceeds the competitor’s pace.
-100.00%
Both reduced dividends long-term. Martin Whitman might check if sector-level headwinds forced universal cuts.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.